Literature DB >> 1747988

Cigarette smoking and addiction.

C Cohen1, W B Pickworth, J E Henningfield.   

Abstract

Tobacco use is a form of drug addiction, as shown by studies assessing the abuse liability of tobacco and nicotine in humans and animals. Tobacco experimentation frequently leads to daily use, which is characterized by a highly consistent pattern of drug intake. Such a pattern is controlled by the biologic concentrations of nicotine, a psychoactive constituent of tobacco smoke. Nicotine is a euphoriant, self-administered by humans as well as by animals in laboratory settings. Nicotine controls smokers' behavior in such a way that reducing or suppressing tobacco consumption produces a withdrawal syndrome characterized by irritability, difficulty concentrating, cognitive impairments, and weight gain. Nonpharmacologic factors are also important determinants of tobacco addiction that interfere with successful cessation. Strategies to treat tobacco addiction are comparable to those developed for other drug addictions. For example, therapy may include the use of alternate forms of nicotine and possibly also nicotine antagonists and medications targeted to alleviate specific withdrawal symptoms, if such therapies become available. As in all drug addiction treatment strategies, behavioral intervention is important whether or not a medication is used.

Entities:  

Mesh:

Year:  1991        PMID: 1747988

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  8 in total

1.  Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors.

Authors:  Arthur L Brody; Mark A Mandelkern; Edythe D London; Richard E Olmstead; Judah Farahi; David Scheibal; Jennifer Jou; Valerie Allen; Emmanuelle Tiongson; Svetlana I Chefer; Andrei O Koren; Alexey G Mukhin
Journal:  Arch Gen Psychiatry       Date:  2006-08

Review 2.  Functional brain imaging of tobacco use and dependence.

Authors:  Arthur L Brody
Journal:  J Psychiatr Res       Date:  2005-06-24       Impact factor: 4.791

Review 3.  Cigaret smoking and the lung.

Authors:  S Murin; J Hilbert; S J Reilly
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 10.817

Review 4.  In vivo brain imaging of human exposure to nicotine and tobacco.

Authors:  Anil Sharma; Arthur L Brody
Journal:  Handb Exp Pharmacol       Date:  2009

Review 5.  Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.

Authors:  Lauren C Smith; Olivier George
Journal:  Neuropharmacology       Date:  2020-08-03       Impact factor: 5.250

Review 6.  Nicotine-related brain disorders: the neurobiological basis of nicotine dependence.

Authors:  E L Ochoa
Journal:  Cell Mol Neurobiol       Date:  1994-06       Impact factor: 5.046

7.  Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats.

Authors:  Lauren C Smith; Lani Tieu; Raymond T Suhandynata; Brent Boomhower; Melissa Hoffman; Yadira Sepulveda; Lieselot L G Carrette; Jeremiah D Momper; Robert L Fitzgerald; Kate Hanham; Joseph Dowling; Marsida Kallupi; Olivier George
Journal:  Psychopharmacology (Berl)       Date:  2021-04-28       Impact factor: 4.415

8.  Barriers to smoking cessation: a qualitative study from the perspective of primary care in Malaysia.

Authors:  Kooi-Yau Chean; Lee Gan Goh; Kah-Weng Liew; Chia-Chia Tan; Xin-Ling Choi; Kean-Chye Tan; Siew-Ting Ooi
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.